Status:

COMPLETED

GORE® Embolic Filter in Carotid Stenting for High Risk Surgical Subjects (EMBOLDEN)

Lead Sponsor:

W.L.Gore & Associates

Conditions:

Carotid Artery Stenosis

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

Compare the 30-day safety and efficacy of the GORE® Embolic Filter used in conjunction with FDA-approved carotid stents to a performance goal obtained from carotid stent studies utilizing distal embol...

Detailed Description

Continuous advances in angioplasty techniques and the development of low-profile, flexible, tapered nitinol stents designed specifically for carotid applications have made CAS a viable alternative to ...

Eligibility Criteria

Inclusion

  • Subject is either:
  • Symptomatic (amaurosis fugax in the hemisphere supplied by the target vessel, TIA or non-disabling stroke within 6 months of the procedure) with carotid stenosis ≥50% as diagnosed by angiography using NASCET methodology, OR
  • Asymptomatic with carotid stenosis ≥80% as diagnosed by angiography using NASCET methodology
  • Target lesion is located in one of the following:
  • ICA
  • bifurcation
  • CCA proximal to the bifurcation
  • At Anatomic risk for adverse events from CEA (e.g., restenosis after a prior CEA) or at Co-morbid risk for adverse events from CEA (e.g., unstable angina with ECG changes)

Exclusion

  • Recent surgical procedure within 30 days before or after the stent procedure
  • Uncontrolled sensitivity to contrast media
  • Renal Insufficiency
  • Recent evolving, acute stroke within 21 days of study evaluation
  • Myocardial infarction within 72 hours prior to stent procedure
  • History of a prior major ipsilateral stroke with residual neurological deficits likely to confound the neurological assessments (e.g., NIHSS)
  • Neurological deficits not due to stroke likely to confound the neurological assessments (e.g., NIHSS)
  • Angiographic

Key Trial Info

Start Date :

January 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2010

Estimated Enrollment :

250 Patients enrolled

Trial Details

Trial ID

NCT00766493

Start Date

January 1 2009

End Date

July 1 2010

Last Update

September 29 2016

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

GORE® Embolic Filter in Carotid Stenting for High Risk Surgical Subjects (EMBOLDEN) | DecenTrialz